首页> 外文期刊>ACS medicinal chemistry letters >Synthesis and Antitumor Activity of C-7-Alkynylated and Arylated Pyrrolotriazine C-Ribonucleosides
【24h】

Synthesis and Antitumor Activity of C-7-Alkynylated and Arylated Pyrrolotriazine C-Ribonucleosides

机译:C-7-炔蛋白化和芳基吡咯三嗪c-核糖核苷的合成与抗肿瘤活性

获取原文
获取原文并翻译 | 示例
       

摘要

A number of biologically active nucleoside analogues contain the adenine isostere 4-amino-pyrrolo[2,1-f][1,2,4]triazine connected to various sugar moieties through a C-C anomeric linkage. We employed palladium-catalyzed crosscoupling chemistry to promptly functionalize the 7-position of such a heterocyclic scaffold with various alkynyl and aryl groups starting from a common 7-iodo-pyrrolotriazine C-ribonucleoside intermediate. Analogues bearing a 7-cyclopropyl-, 7-propyl-, and 7-butylacetylene moiety displayed potent cytotoxic activity, with the latest being the most selective of this series toward cancer cells. Further insights revealed that such C-nucleosides could exert their antiproliferative action by causing dose-dependent DNA damage.
机译:许多生物活性核苷类似物含有腺嘌呤等升4-氨基-Pyrrolo [2,1-F] [1,2,4]三嗪通过C-C异组键连接到各种糖部分。 我们使用钯催化的交叉耦合化学,以从常见的7-碘 - 吡咯三嗪c-核糖核苷中间体开始使用各种炔基和芳基的这种杂环支架的7-位。 载有7-环丙基,7-丙基和7-丁基乙炔部分的类似物显示出有效的细胞毒性活性,最新是该系列对癌细胞的最佳选择性。 进一步的见解显示,这种C-核苷可以通过引起剂量依赖性的DNA损伤来施加抗增殖作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号